Farxiga and Nosebleed - from FDA reports


Nosebleed is found among people who take Farxiga, especially for people who are female, 60+ old , have been taking the drug for 6 - 12 months, also take medication Cymbalta, and have Type 2 diabetes. This study is created by eHealthMe based on reports of 4,589 people who have side effects when taking Farxiga from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and find Care Guides (see testimonials).



On Sep, 12, 2018

4,589 people reported to have side effects when taking Farxiga.
Among them, 8 people (0.17%) have Nosebleed


Number of reports submitted per year:

Could Farxiga cause Nosebleed?

Time on Farxiga when people have Nosebleed *:

Gender of people who have Nosebleed when taking Farxiga *:

  • female: 75 %
  • male: 25 %

Age of people who have Nosebleed when taking Farxiga *:

Top conditions involved for these people *:

  1. Type 2 Diabetes: 3 people, 37.50%
  2. Tardive Dyskinesia (a disorder that involves involuntary movements): 1 person, 12.50%
  3. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 12.50%
  4. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 12.50%
  5. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 12.50%

Click here to view more results or personalize the results to your gender and age

Top co-used drugs for these people *:

  1. Levemir: 2 people, 25.00%
  2. Lasix: 2 people, 25.00%
  3. Trulicity: 2 people, 25.00%
  4. Cymbalta: 2 people, 25.00%
  5. Zyrtec: 1 person, 12.50%

Click here to view more results or personalize the results to your gender and age

Top other side effects for these people *:

  1. Rashes (redness): 2 people, 25.00%
  2. Mouth Haemorrhage (bleeding from mouth): 2 people, 25.00%
  3. Trigger Finger: 2 people, 25.00%
  4. High Blood Cholesterol: 2 people, 25.00%
  5. Eye Haemorrhage (bleeding in the eye): 1 person, 12.50%

Click here to view more results or personalize the results to your gender and age

* Approximation only. Some reports may have incomplete information.

FDA reports used in this study



Are you new to Farxiga or have questions?

On eHealthMe, Care Guides are people who "have been there". Many of them have been living or working with a drug, a condition, or both for a long time and gained substantial experience. Follow a Care Guide below to get answers between doctor visits, and guidance in everyday life.


More Care Guides for: Farxiga, Nosebleed

Volunteer or get paid to help people with your care experience



Do you have Nosebleed while taking Farxiga?



Related studies

Farxiga

Farxiga has active ingredients of dapagliflozin. It is often used in diabetes. (latest outcomes from Farxiga 4,644 users)

Nosebleed

Nosebleed (bleeding from nose) has been reported by people with atrial fibrillation/flutter, stroke, high blood pressure, thrombosis, rheumatoid arthritis (latest reports from 54,333 Nosebleed patients).


Drugs that are associated with Nosebleed
Nosebleed (2,400 drugs)
Could your condition cause Nosebleed
Nosebleed (2,326 conditions)
Farxiga side effects
Browse all side effects of Farxiga
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Farxiga and have Nosebleed


Recent updates

General studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.